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Total Knee Arthroplasty in a Low-Income Country
Short-Term Outcomes from a National Joint Registry
Simon Matthew Graham, MBChB, MRCS, MSc (Res), FRCS, Chipiliro Moffat,
Nicholas Lubega, BMBS, FCS(ECSA), Nyengo Mkandawire, BMBS, FRCS, MCh(Orth), FCS(ECSA),
David Burgess, MD, and William J. Harrison, MA(Oxon), FRCS(Tr&Orth)
Investigation performed at Beit CURE International Hospital, Blantyre, Malawi
Background: We describe our 10-year experience with total knee arthroplasty in patients who are included in the Malawi
National Joint Registry.
Methods: A total of 127 patients underwent 153 total knee arthroplasties (TKAs) between 2005 and 2015. The mean
duration of follow-up was 4 years and 3 months (range, 6 months to 10 years and 6 months). The study group included 98
women and 29 men with a mean age of 65.3 years (range, 24 to 84 years). Nine patients were human immunodeﬁciency
virus (HIV)-positive.
Results: The primary indication for surgery was osteoarthritis (150 knees), and the mean preoperative and postop-
erative Oxford Knee Scores were 16.81 (range, 4 to 36) and 45.61 (range, 29 to 48), respectively. Four knees (2.6%)
were revised because of early periprosthetic joint infection (1 knee), aseptic loosening (1 knee), and late periprosthetic
joint infection (2 knees). There were no perioperative deaths. In the group of 9 patients who were HIV-positive, there
were no early or late complications and the mean Oxford Knee Score was 47 (range, 42 to 48) at the time of the latest
follow-up.
Conclusions: This study demonstrated good short-term results following 153 primary TKAs performed in a low-income
country.
Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
I
n a low-income-country setting, such as in sub-Saharan
Africa, the numbers of total joint arthroplasties (TJAs)
being performed are increasing. There are a number of
reasons for this increase, including the wider availability of
surgical resources and expertise and an increase in life expec-
tancy in these settings1,2. Additionally, there is a growing trend
in the use of this form of orthopaedic surgery3,4.
Our institute, Beit CURE International Hospital (BCIH),
is an example of a health-care model in which the hospital
provides a private elective hip and knee arthroplasty service that
funds free health care for those most in need. The Malawi
National Joint Registry (MNJR) was established to ensure that
patients who had undergone a TJA inMalawi were followed and
that their surgical and functional outcomes were accurately
recorded for the purposes of both clinical governance and
research4. All patients who have undergone TJA at our institute
have been entered into the registry.
Very little is known about the long-term or short-term
results of total knee arthroplasty (TKA) in low-income coun-
tries. Furthermore, it is not known how the results of TKA in
low-income countries compare with those in high-income
countries4. The key areas of interest are patient demographics,
etiology, complications, patient-reported outcomes, and sur-
vivorship. We describe our experience with primary TKA in a
low-income country over a 10-year period, with the aim of
providing a benchmark against which other hospitals and reg-
istries can compare their outcomes.
Materials and Methods
All patients who had undergone TKA at our institutionbetween December 2005 and January 2015 were iden-
tiﬁed through the MNJR and were included in the present
study (Fig. 1). All data presented in the current study were
derived from the MNJR. The registry was established in 2005,
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with ethical approval from the Research Ethics Committee of
the College of Medicine of the University of Malawi. At the
time of the study, 177 primary TKAs in 151 patients (113
women and 38 men) had been performed at BCIH and
entered into the registry. The mean age at the time of surgery
was 66.2 years (range, 24 to 84 years). Twenty-six patients
(21 women and 5 men) underwent bilateral TKAwith staged
procedures.
In our review of the database, we identiﬁed 9 human
immunodeﬁciency virus (HIV)-positive patients (5 men
and 4 women) with a mean age of 60.8 years (range, 49 to
72 years) who had undergone primary unilateral TKA.
The indication for TKA was osteoarthritis in 8 of these
patients and rheumatoid arthropathy in 1. All but 1 of
the patients were aware of their HIV status and had
been taking highly active antiretroviral therapy (HAART)
preoperatively.
The procedures were performed by 6 different surgeons,
and all of the procedures were performed at BCIH. None of the
hospital operating theaters had a laminar-ﬂow system. The
majority (174) of the TKA procedures were performed for
the treatment of symptomatic osteoarthritis. Other indications
included osteonecrosis (1 knee); rheumatoid arthritis (1 knee),
and sickle-cell arthropathy (1 knee).
A PFC cruciate-retaining prosthesis (DePuy Orthopaedics)
with ametal tray and polyethylene insert was used in 171 knees,
a PFC cruciate-sacriﬁcing prosthesis (DePuy Orthopaedics)
was used in 2 knees, and an AGC prosthesis (Biomet) was
used in 4 knees. None of the patients underwent patellar
resurfacing. All of the implants were secured with use of
Smartset GHV cement with gentamicin (DePuy), and the
patients received a single dose of intravenous antibiotic at
the start of surgery. The antibiotic that was used was either
cefuroxime or, for patients with a penicillin allergy, genta-
micin. The majority of procedures were performed with use
of spinal anesthesia. The mean duration of hospitalization
was 8.2 days (range, 5 to 20 days).
Thromboembolism-deterrent (TED) graduated com-
pression stockings were used, along with low-dose aspirin, for a
period of 6 weeks after each operation. All patients were
mobilized on the ﬁrst postoperative day.
After the operation, a senior research nurse, in partner-
ship with a senior surgeon, evaluated all patients at 6 weeks, 3
and 6 months, and annually thereafter. The patients were as-
sessed for pain, postoperative complications, and function with
use of the Oxford Knee Score (OKS). In 2015, we introduced
recording of the OKS during all of the preoperative and post-
operative assessments of patients undergoing TKA. Therefore,
in the present study, the postoperative scores were available for
all patients but the preoperative scores were available for only
some patients.
The surgical wounds and/or scars were inspected and
assessed with use of the ASEPSIS wound-scoring system5,
which assigns a total possible score of 70 on the basis of
the appearance of the wound as well as additional treat-
ments required. For the purposes of the present study, a
score of >10 was considered to be indicative of an infec-
tion, a system that has been approved by National Institute
for Health and Clinical Excellence (NICE) in the United
Kingdom (U.K.)6.
Anteroposterior and lateral radiographs of the knee
were made at each follow-up appointment. At the most
Fig. 1
Current patient ﬂow protocol for the management of patients undergoing
total knee replacement andentered into theMalawiNational Joint Registry.
TKR = total knee replacement, OKS = Oxford Knee Score, MDT = multi-
disciplinary team, and TED = thromboembolism-deterrent.
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recent follow-up, the radiographs were reviewed by the ﬁrst
author (S.M.G.), who had not been involved in the surgical
procedures and who assessed the images for signs of loos-
ening. For all HIV-positive patients, the CD4 count was
rechecked annually.
Malawi has a national policy (established in 2005) of
using oral co-trimoxazole (trimethoprim-sulfamethoxazole),
at a dose of 960 mg daily, as a prophylactic antibiotic for all
HIV-positive patients. No information on compliance with this
national policy was available for the present study7.
Results
Of the 151 patients (177 knees) who underwent primaryTKA, 24 patients (24 knees) were unavailable at the most
recent follow-up and were excluded from the analysis (Table I).
All 24 patients were seen at 6 months postoperatively, but no
further follow-up was available. All 24 patients had undergone
unilateral TKA. Of these 24 patients, 16 (11 fromMalawi and 5
from Zimbabwe), representing 11% of the original group, died
before the latest follow-up, and the remaining 8 (2 fromMalawi
and 6 from Zimbabwe), representing 5% of the original group,
were lost to follow-up. None of the patients died within
6 months after surgery. No revision procedures were per-
formed in any of the patients who were lost to follow-up. None
of the patients who were lost to follow-up had HIV. Therefore,
127 patients (98 women and 29 men) with a mean age of 65.3
years (range, 24 to 84 years) who had undergone a total of 153
primary TKAs were included in the ﬁnal analysis. Of these, 26
patients had had staged bilateral TKA. The mean duration of
follow-up was 4 years and 3 months (range, 6 months to 10
years and 6 months).
One patient developed an early postoperative peri-
prosthetic joint infection within 6 weeks postoperatively and
was successfully managed with early irrigation, debride-
ment, and antibiotic therapy. Methicillin-sensitive Staphy-
lococcus aureus infection was identiﬁed on the basis of
microbiological sampling. One patient developed tibial
aseptic loosening at 2 years and underwent successful revi-
sion surgery at our institute. Two patients developed late
periprosthetic joint infections at 1 year and 3 years postop-
eratively. One of these patients was managed with implant
removal and insertion of a permanent antibiotic cement
spacer at our institute. The other patient underwent revision
surgery abroad and subsequently developed an infection at
the site of the revision implant. No further revision proce-
dures were performed in any of the patients. Thus, the
overall revision rate was 2.6% (4 of 153).
There were no other early complications (£6 weeks
postoperatively) or late complications (>6 weeks postop-
eratively) such as aseptic loosening, dislocation, sympto-
matic deep-vein thrombosis, or pulmonary embolism. No
other patients had any symptoms consistent with aseptic
loosening, such as pain, dislocation, or alteration in the
level of postoperative mobility. Furthermore, radiographs
demonstrated no evidence of aseptic loosening in any
patient at the time of the latest follow-up. The rates of
inpatient mortality and overall mortality at 6 weeks and
12 months postoperatively were all 0%. To our knowledge,
none of the 16 deaths that occurred later were related to the
arthroplasty.
The mean preoperative OKS was 16.81 (range, 4 to 36)
for the 48 patients who had available data. The mean postop-
erative OKS was 45.61 (range, 29 to 48) after a mean duration
of follow-up of 4 years and 3 months (range, 6 months to 10
years 6months). The 4 patients who had >10 years of follow-up
had a mean OKS of 46 (range, 45 to 48), and the 18 patients
with ‡5 years of follow-up had a mean OKS of 47 (range, 45
to 48).
Of the patients who were HIV-positive, none had any
early or late complications and none had died at the time of
the latest follow-up. The mean OKS for these patients was 47
(range, 42 to 48), and no patient had symptoms of aseptic
loosening at the time of the latest follow-up. All HIV-
positive patients were taking HAARTat the time of the latest
follow-up.
Discussion
The present study demonstrated good short-term resultsfollowing primary TKA in 127 patients (153 knees) in a
low-income country. To our knowledge, this study is the largest
such study to date and is the ﬁrst to evaluate outcomes, com-
plications, and infection rates associated with TKA in a low-
income country. The study demonstrated a 0% perioperative
mortality rate at 6 months and a 2.6% overall revision rate at a
TABLE I Demographic Data on Patients in Malawi National Joint Registry
Entered into
the Registry*
Lost to
Follow-up*
Followed in
Registry* HIV-Positive* Indication for Surgery† Type of Implant†
151 (177) 24 (24) 127 (153) 9 (9) Osteoarthritis (174),
osteonecrosis (1),
rheumatoid arthritis (1),
sickle-cell arthropathy (1)
PFC cruciate-retaining
prosthesis (171),
PFC cruciate-sacriﬁcing
prosthesis (2), Biomet
AGC prosthesis (4)
*The values are given as the number of patients undergoing TKA, with the number of knees in parentheses. †The number of knees is given in
parentheses.
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mean duration of follow-up of 4 years and 3 months, with
excellent and sustained functional outcomes in this cohort.
The study demonstrated good functional outcomes and
low infection rates in a small cohort of HIV-positive patients
with no history of hemophilia or intravenous drug use who
underwent TKA in a low-income country. Although that
subgroup of patients was small, we believe that it is still the
largest of its type in the literature to date.
A small number of similar studies have been reported in
the literature; however, those studies commonly have involved
very small patient cohorts and have included limited data on
outcomes and complications7-11 (Table II). Additionally, of the 5
similar studies known to us, 3 were from Botswana and the
Dominican Republic, which are classiﬁed as upper-middle-
income countries by the World Bank7-11. The other 2 studies
included only 7 and 8 TKAs and were from Zambia and Ghana,
respectively, which are classiﬁed as middle-income coun-
tries10,12,13. Therefore, our results are the only reported from a
low-income country12.
As a low-income country, Malawi has a gross national
income (GNI) of £$1,005 per capita, whereas high-income
economies have a GNI of ‡$12,236 per capita, as calculated
with use of the World Bank Atlas method12. Little is known
about the indications for TKA in low-income countries and
if they are the same as those in high-income countries. In the
U.K., osteoarthritis was the sole stated indication for 96% of
the 871,472 primary knee replacements that were entered into
the National Joint Registry from 2002 to 201614. This ﬁnding is
similar to our experience in Malawi and also to those in other
studies from low and middle-income countries7-11.
A total of 57% of primary knee replacement procedures
in the U.K. in 2002 to 2016 were performed in women14,
whereas the MNJR demonstrated a much higher proportion
of female patients (77%). Again, the male:female ratio
among patients undergoing total hip arthroplasty (THA) in
this low-income setting is more balanced2. Furthermore,
patients in the MNJR were slightly younger than those in the
U.K. (mean age, 65.3 compared with 70 years)14. Although
not reported in the U.K. National Joint Registry, it is likely
that the MNJR includes a larger proportion of HIV-positive
patients who have undergone TKA, as the prevalence of HIV
is approximately 9.1% in Malawi15 compared with 0.16% in
the U.K.16.
The patients in the MNJR had a mean OKS of 45.61
(range, 29 to 48) at a mean of 4 years and 3 months of follow-
up, whereas those in the U.K. National Joint Registry had a
mean OKS of 39 (range, 29 to 44) at 36 months of follow-up14.
This difference in OKS between the Malawi and U.K. NJR
potentially could be explained by varying levels of patient
expectation; however, this explanation is speculative and, to
our knowledge, this is the ﬁrst comparison available in the
literature.
There has been an increase in the number of primary
TJAs being performed by visiting surgical teams in low-income
countries, including Malawi. Reports have demonstrated
mixed success in association with this approach to health-care
provision3,11, with some groups reporting concerning rates of
complications17. These visiting surgical teams may not have the
experience of operating in a low-income setting, and, on
occasion, no follow-up is provided, even in the short term.
TABLE II Summary of Studies* 
Study Date Country No. of TKAs Age† (yr)
Sex (no. of
patients)
Indication (No. of
Knees)
HIV-
Positive
(no. of
patients)
Current study December 2005 to
January 2016
Malawi 153 (101 unilateral,
52 bilateral)
65.3 (24 to 84) 98 female, 29
male
OA (150), ON (1),
SCA (1), RA (1)
9
Lisenda
et al.9(2016)
March 2009 to October
2015
Botswana 193 (170 unilateral,
23 bilateral)
64.5 (26 to 86) NR‡ OA (189), RA (4) Not stated
Lisenda
et al.8 2016
February 2009 to
November 2010
Botswana 58 (51 unilateral, 7
bilateral)
65.6 (46 to 81) 46 female, 5 male OA (53), RA (5) 0
Niu et al.11
(2011)
March 2009 to March
2010
Dominican Republic 55 (34 unilateral, 21
bilateral)
Not stated Not stated Not stated Not stated
Mulla et al.13
(2010)
1998 to 2010 (months
not stated)
Zambia 7 Not stated Not stated Not stated Not stated
George
et al.10
(2009)
October 2006 to
October 2007
Ghana 8 (7 unilateral,
1 bilateral)
Median, 59.3 (48
to 71)
6 female, 1 male OA (8) 0
*TKA = total knee arthroplasty, HIV = human immunodeﬁciency virus, OA = osteoarthritis, ON = osteonecrosis, SCA = sickle-cell arthropathy, RA = rheumatoid arthritis, OKS = Oxford Knee Score,
PPJI=periprosthetic joint infection, PE=pulmonary embolism,WOMAC=WesternOntario andMcMaster UniversitiesOsteoarthritis Index, andSF-36=Short Form-36questionnaire.†The valuesare
given as themean, with the range in parentheses or as themean and the standard deviation.‡NR= not reported. The study did not specify the numbers ofmale and female patients who had bilateral
involvement.
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Therefore, it is important to ensure that these patients are
followed in registries such as the MNJR. Furthermore, we are
not aware of any published reports on TKAs performed by
visiting teams in low-income countries; all of the reported
results to date have pertained to THAs.
Our 10-year experience with, and short-term results of,
primary TKA in a low-income setting show that good results
can be achieved and sustained in a controlled hospital envi-
ronment. Our results provide a benchmark against which other
hospitals and registries in low-income countries can compare
their outcomes. Currently, the only benchmarks are from high-
income countries, which may not be comparable. We
encourage other countries in our region to establish joint
registries. Comparative registries will highlight strengths and
weaknesses in different forms of arthroplasty service, including
TJA “camps”, where international surgeons provide visiting
arthroplasty services in areas where no services are available.
Comparative registries can help to focus training or adjustment
of clinical practice, and thus optimize good clinical governance
for TJA in the region. Furthermore, pooling the data may allow
conclusions about long-term outcomes to be derived earlier. n
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to this, funding was provided by the British Orthopaedic Association Joint Action Fund. They also
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funding.
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